SCHEMBL6772875

SCHEMBL6772875

CC1=C(C)N(CC(=O)c2ccccn2)CS1.Cc1sc[n+](CC(=O)N2CCCCC2C)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
ATM Q13315 1/20 0.38
RAB9A P51151 5/20 0.36
MAPK1 P28482 2/20 0.36
MAPT P10636 1/20 0.36
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
CPT1A P50416 2/20 0.34
KDM4E B2RXH2 2/20 0.34
USP2 O75604 1/20 0.34
PABPC1 P11940 1/20 0.34
CPT2 P23786 1/20 0.34
NPC1 O15118 1/20 0.33
TRPC3 Q13507 1/20 0.33
TRPC6 Q9Y210 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5978880 0.84 ALDH1A1 (0.38) ALDH1A1ATMRAB9AMAPK1MAPT
Bromide SCHEMBL7050720 0.81 ALDH1A1 (0.36) ALDH1A1ATMRAB9AMAPK1MAPT
Hydrochloric Acid SCHEMBL3848955 0.80 HPGD (0.44) ALDH1A1ATMRAB9AMAPK1CHRM2
SCHEMBL5071288 0.79 HPGD (0.45) ALDH1A1ATMRAB9AMAPK1CHRM2
SCHEMBL5071273 0.77 CTNNB1 (0.45) ALDH1A1RAB9AKMT2AKDM4ENPC1
Bromide SCHEMBL3843813 0.76 CTNNB1 (0.44) ALDH1A1RAB9AKMT2AKDM4ENPC1
Bromide SCHEMBL5015757 0.75 KMT2A (0.44) ALDH1A1RAB9AMAPTKMT2AKDM4E
SCHEMBL6772878 0.72 ALDH1A1 (0.43) ALDH1A1ATMRAB9AMAPK1MAPT
SCHEMBL5071271 0.71 KMT2A (0.52) ALDH1A1RAB9AKMT2ANPC1SMN1; SMN2
SCHEMBL5071291 0.71 GAA (0.46) ALDH1A1ATMRAB9AMAPK1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6790859-B2 THERAPY OR REDUCING PROGRESSION OF HYPERTENSION OR DAMAGE TO A TISSUE CAUSED BY CONTACT WITH ELEVATED LEVELS OF REDUCING SUGARS IN AN ANIMAL, COMPRISING ADMINISTERING TO THE ANIMAL AN EFFECTIVE AMOUNT OF THIAZOLIUM COMPOUNDS ALTEON INCORPORATED 2004-09-14 US claimed